10% Earnings per share (THB/share) 0.59 0.54 0.05 10% 2 / 4 Consolidated financial results of 12-month ended period Declining in sales revenue of 2019 8%, mainly are from declining in G-G contract
% Earnings per share (THB/share) 0.59 0.54 0.05 10% 2 / 4 Consolidated financial results of 12-month ended period Declining in sales revenue of 2019 8%, mainly are from declining in G-G contract and closing
one-time tax loss carry forward incurred under our hardline segment in the year ended December 31, 2017. 10. Total adjustment to earnings, pre-tax was THB 3,072 million for the year ended December 31
strengthened over last 2 years with record earnings and conversion of warrants into equity. In early 2019 as part of our Capital Market Day, we had identified our Integrated Oxides and Derivatives segment and
associated contribution to earnings in 2019, 2020 and 2021. These new segments are as follows: 1. Integrated PET This segment will include businesses in the aromatics and PET value chain. Given PET’s unique
sales from fashion segment 14,845 27.8% 15,217 30.2% (372) (2.4%) - Revenue from sales from hardline segment 13,294 24.9% 9,515 18.9% 3,779 39.7% - Revenue from sales from food segment 19,641 36.8% 19,923
12.3% - Revenue from sales from fashion segment 18,092 28.5% 17,324 32.4% 768 4.4% - Revenue from sales from hardline segment 14,716 23.2% 10,545 19.7% 4,172 39.6% - Revenue from sales from food segment
each segment operating performance. The PET segment performance stood out as its core EBITDA more than doubled from $57 million in 1Q 2017 to $116 million in 1Q 2018. PET earnings in the Western markets
negative impact on this segment for 1Q19 and also for over a month of 2Q19. Core EBITDA in 1Q19 was $3 million (-97% YoY; -95% QoQ). The decline in earnings of the segment was due to the EO-EG plant shutdown
2019. This has a negative impact on this segment for 1Q19 and also for over a month of 2Q19. Core EBITDA in 1Q19 was $3 million (-97% YoY; -95% QoQ). The decline in earnings of the segment was due to the